Chinese instructions for Asciminib
Indications: Asciminib (Asciminib) is an innovative drug used to treat chronic myeloid leukemia (Chronic Myeloid Leukemia, CML). It is suitable for patients with CML who have become resistant or intolerant to traditional treatments, especially those with CML caused by mutations in the BCR-ABL gene.
Mechanism of action: The mechanism of action of aceminib involves the following key aspects:
1.BCR-ABLProtein inhibition: BCR-ABLprotein is the main pathogenic factor of CML, which promotes the excessive proliferation of abnormal white blood cells. Aceminib interrupts this abnormal cell growth mechanism by inhibiting the activity of the BCR-ABL protein.
2.NonATPcompetitive inhibition: Unlike traditional tyrosine kinase inhibitors, aceminib is a nonATPcompetitive inhibitor and does not interfere with the binding of ATP to protein kinases. This reduces the risk of drug resistance.
Pharmacology: The pharmacological characteristics of Asiminib include:
1.Absorption: Aceminid is usually taken after a meal to increase its bioavailability.
2.Distribution: It is widely distributed in the body, including entering red blood cells.
3.Metabolism: Aceminib is mainly metabolized by the liver and participates in multiple metabolic pathways.
4.Excretion: It is mainly excreted through the kidneys in the form of metabolites.
Dosage and Usage: The dosage and usage of Aceminib should be based on the patient’s specific conditions and the doctor’s prescription. In general, it is recommended to follow the following guidance:
1.Adult patients: The initial dose is usually 50 mg once daily.
2.Usage: Aceminid should be taken after a meal with a glass of water.
3.Adjust the dosage: The doctor may adjust the dosage according to the patient's response and needs to achieve the best effect.
4.Special circumstances: In certain patient groups, such as the elderly, patients with impaired hepatic function, or patients with impaired renal function, dosage adjustments may be necessary.

Side Effects: Aximini may cause a series of side effects, including but not limited to:
1.Nausea and vomiting: Nausea and vomiting are the most common side effects and usually occur early in treatment.
2.Diarrhea: Diarrhea is also common, and patients may need to make moderate adjustments to their diet to relieve discomfort.
3.Fatigue: Some patients may feel tired and need to arrange rest and activities appropriately.
4.Headache: Mild headaches may occur but are usually relieved with over-the-counter medications.
5.Skin rash: Skin rash is a possible side effect and patients should report it to their doctor for advice.
Warnings and Precautions: Patients need to pay attention to the following warnings and precautions when using Asiminib:
1.Heart monitoring: Because aceminib may cause heart problems, patients should receive regular heart monitoring, including an electrocardiogram.
2.Bleeding risk: Patients should take care to avoid injury and promptly report any abnormal bleeding.
3.Liver function monitoring: Because liver function abnormalities may occur, patients should receive regular liver function tests during treatment.
4.Drug Interactions: Patients should inform their doctors of all medications they are taking to avoid potential drug interactions.
Contraindications: Aximini is contraindicated in the following circumstances:
1.Patients who are allergic to drug ingredients.
2.Pregnant and lactating women, unless advised by a physician.
Drug Interactions: Aximini may interact with other drugs, including but not limited to:
1.CYP3A4Inducers and inhibitors: These drugs may affect the metabolism of aceminib and need to be used with caution.
2.Ketoconazole and itconazole: These antifungals may increase the plasma concentrations of aceminib.
3.Anticoagulants: Aceminid may increase the risk of bleeding, so caution should be used together with anticoagulants.
Medication for Special Populations: In the elderly and patients with impaired liver or renal function, the medication of aximini may need to be adjusted, and the doctor will make appropriate dosage adjustments based on the patient's specific conditions.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)